GE-38 * IDENTIFYING THE TREATMENT-RESISTANT MESENCHYMAL SIGNATURE BY COMPARATIVE ANALYSES BETWEEN GLIOMA SPHERE-FORMING CELLS AND THEIR GLIOBLASTOMAS OF ORIGIN
Qi Wang(BGI Group (China)), Erik P. Sulman(NYU Langone Health), Ravesanker Ezhilarasan(Post Graduate Institute of Medical Education and Research), Giulio Draetta(The University of Texas MD Anderson Cancer Center), Joy Gumin(The University of Texas MD Anderson Cancer Center), F. Lang(The University of Texas MD Anderson Cancer Center), Roeland Verhaak(Broad Institute), Thomas P. Heffernan(The University of Texas MD Anderson Cancer Center), Siyuan Zheng(Third Affiliated Hospital of Guangzhou Medical University)
Cited by 0
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k